At least 17 oncolytic virus therapies are in development for various cancers. (A) Received rights to oncolytic virus programs from MediGene AG (Xetra:MDG); (B) Received rights to CG0070 from BioSante Pharmaceuticals Inc. (NASDAQ:BPAX); Source: BCIQ: BioCentury Online Intelligence

Company

Product

Description

Indication

Status

Shanghai Sunway Biotech Co. Ltd.

Oncorine

Modified adenovirus with deletion of an E1B-55kd segment

Head and neck cancer

Mkt (China)